Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Clearside Biomedical Inc CLSD

Healthcare
Clearside Biomedical, Inc. is a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space (SCS). The Company's SCS injection platform, utilizing its patented SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina, or... see more

Recent & Breaking News (NDAQ:CLSD)

Clearside Biomedical Appoints Accomplished Pharmaceutical Industry Legal Executive, Leslie Zacks, as General Counsel and Chief Compliance Officer

GlobeNewswire September 11, 2018

Clearside Biomedical to Participate in 2018 Janney Healthcare Conference

GlobeNewswire September 10, 2018

Clearside Biomedical Further Strengthens Commercial Organization With Appointment of Lester Rodríguez as Vice President, Quality

GlobeNewswire September 6, 2018

Clearside Biomedical to Participate in 2018 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 9, 2018

Clearside Biomedical Announces Second Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire August 8, 2018

Clearside Biomedical to Report Second Quarter 2018 Financial Results on August 8, 2018 – Conference Call to Follow

GlobeNewswire August 1, 2018

Clearside Biomedical to Present Data from its Pivotal Phase 3 (“PEACHTREE”) Trial in Macular Edema Associated with Uveitis at the 2018 American Society of Retina Specialists Annual Meeting

GlobeNewswire July 16, 2018

Clearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs

GlobeNewswire July 11, 2018

Clearside Biomedical Announces Completion of Patient Enrollment in First of Two Phase 3 Clinical Trials of CLS-TA in Retinal Vein Occlusion

GlobeNewswire June 13, 2018

Clearside Biomedical to Participate in 2018 JMP Securities Life Sciences Conference

GlobeNewswire June 11, 2018

Mid-Afternoon Market Update: J.Jill Climbs On Earnings Beat; Scpharmaceuticals Shares Fall

Benzinga.com  May 31, 2018

Clearside Biomedical Announces Positive Topline Results from Phase 2 Clinical Trial of CLS-TA Used with Eylea in Patients with Diabetic Macular Edema

GlobeNewswire May 31, 2018

Clearside Biomedical to Present at the 2018 UBS Global Health Care Conference

GlobeNewswire May 16, 2018

Clearside Biomedical Announces First Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire May 9, 2018

Clearside Biomedical to Report First Quarter 2018 Financial Results on May 9, 2018 – Conference Call to Follow

GlobeNewswire May 2, 2018

Recent Analysis Shows Clearside Biomedical, tronc, Stifel Financial, Woodward, WisdomTree Investments, and Aluminum Corporation of China Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire April 5, 2018

Clearside Biomedical to Present at the 17th Annual Needham Healthcare Conference

GlobeNewswire March 21, 2018

Clearside Biomedical Announces Fourth Quarter 2017 Financial Results and Provides Corporate Update

GlobeNewswire March 14, 2018

Clearside Biomedical, Inc. to Host Earnings Call

Accesswire March 14, 2018

Clearside Biomedical to Report Fourth Quarter and Full Year 2017 Financial Results on March 14, 2018 – Conference Call to Follow

GlobeNewswire March 8, 2018